Collplant Biotechnologies Ltd
NASDAQ:CLGN
Income Statement
Earnings Waterfall
Collplant Biotechnologies Ltd
Revenue
|
11m
USD
|
Cost of Revenue
|
-1.1m
USD
|
Gross Profit
|
9.8m
USD
|
Operating Expenses
|
-16.5m
USD
|
Operating Income
|
-6.6m
USD
|
Other Expenses
|
-373k
USD
|
Net Income
|
-7m
USD
|
Income Statement
Collplant Biotechnologies Ltd
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||
Revenue |
2
N/A
|
2
+1%
|
3
+9%
|
6
+136%
|
6
+2%
|
5
-12%
|
1
-74%
|
16
+1 025%
|
1
-92%
|
1
-51%
|
1
-5%
|
0
-46%
|
1
+123%
|
11
+1 509%
|
11
-1%
|
11
+2%
|
|
Gross Profit | |||||||||||||||||
Cost of Revenue |
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
Gross Profit |
0
N/A
|
0
-11%
|
0
-15%
|
3
+812%
|
3
+4%
|
3
+2%
|
0
-85%
|
14
+2 817%
|
0
-100%
|
(0)
N/A
|
(0)
-89%
|
0
N/A
|
(0)
N/A
|
10
N/A
|
9
-1%
|
10
+4%
|
|
Operating Income | |||||||||||||||||
Operating Expenses |
(8)
|
(8)
|
(8)
|
(8)
|
(9)
|
(8)
|
(9)
|
(14)
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(16)
|
|
Selling, General & Administrative |
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(4)
|
(4)
|
(6)
|
(6)
|
(6)
|
(6)
|
(7)
|
(7)
|
(6)
|
(7)
|
(6)
|
|
Research & Development |
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(8)
|
(8)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
|
Depreciation & Amortization |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Operating Income |
(8)
N/A
|
(8)
-2%
|
(8)
-2%
|
(5)
+31%
|
(6)
-2%
|
(5)
+10%
|
(9)
-76%
|
0
N/A
|
(14)
N/A
|
(15)
-8%
|
(16)
-9%
|
(17)
-4%
|
(17)
0%
|
(7)
+59%
|
(7)
-2%
|
(7)
+7%
|
|
Pre-Tax Income | |||||||||||||||||
Interest Income Expense |
(3)
|
(3)
|
(3)
|
(2)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
1
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(1)
|
|
Total Other Income |
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
|
Pre-Tax Income |
(11)
N/A
|
(11)
+6%
|
(11)
-7%
|
(7)
+34%
|
(6)
+22%
|
(5)
+9%
|
(9)
-72%
|
0
N/A
|
(14)
N/A
|
(15)
-9%
|
(16)
-9%
|
(17)
-4%
|
(17)
+1%
|
(7)
+60%
|
(7)
+0%
|
(7)
-4%
|
|
Net Income | |||||||||||||||||
Income from Continuing Operations |
(11)
|
(11)
|
(11)
|
(7)
|
(6)
|
(5)
|
(9)
|
0
|
(14)
|
(15)
|
(16)
|
(17)
|
(17)
|
(7)
|
(7)
|
(7)
|
|
Net Income (Common) |
(11)
N/A
|
(11)
+6%
|
(11)
-7%
|
(7)
+34%
|
(6)
+22%
|
(5)
+9%
|
(9)
-72%
|
0
N/A
|
(14)
N/A
|
(15)
-9%
|
(16)
-9%
|
(17)
-4%
|
(17)
+1%
|
(7)
+60%
|
(7)
+0%
|
(7)
-4%
|
|
EPS (Diluted) |
-2.24
N/A
|
-1.58
+29%
|
-1.61
-2%
|
-1.05
+35%
|
-0.84
+20%
|
-0.51
+39%
|
-0.86
-69%
|
0.02
N/A
|
-1.27
N/A
|
-1.35
-6%
|
-1.46
-8%
|
-1.53
-5%
|
-1.5
+2%
|
-0.57
+62%
|
-0.58
-2%
|
-0.62
-7%
|